Stockscreener 앱 받기
10.45
2.05%
0.21
시간 외 거래:
10.45
전일 마감가:
$10.24
열려 있는:
$10.22
하루 거래량:
167.50K
Relative Volume:
0.64
시가총액:
$368.93M
수익:
-
순이익/손실:
$-63.78M
주가수익비율:
-3.8993
EPS:
-2.68
순현금흐름:
$-53.91M
1주 성능:
+7.18%
1개월 성능:
-0.48%
6개월 성능:
-35.21%
1년 성능:
-39.39%
1일 변동 폭
$9.98
$10.60
1주일 범위
$9.50
$10.60
52주 변동 폭
$7.575
$19.77
Celcuity Inc Stock (CELC) Company Profile
명칭
Celcuity Inc
전화
763-392-0767
주소
16305 36TH AVENUE N, MINNEAPOLIS, MN
CELC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CELC
Celcuity Inc
|
10.45 | 368.93M | 0 | -63.78M | -53.91M | -2.68 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.52 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.49 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
595.70 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
232.75 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
229.22 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Celcuity Inc Stock (CELC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-22 | 개시 | Leerink Partners | Outperform |
| 2024-02-22 | 개시 | Stifel | Buy |
| 2023-12-08 | 개시 | H.C. Wainwright | Buy |
| 2021-10-08 | 개시 | Canaccord Genuity | Buy |
| 2021-09-07 | 개시 | Jefferies | Buy |
| 2021-07-29 | 개시 | Cowen | Outperform |
| 2021-07-27 | 개시 | Needham | Buy |
| 2021-01-28 | 재확인 | H.C. Wainwright | Buy |
| 2020-12-24 | 재확인 | H.C. Wainwright | Buy |
| 2020-05-11 | 재개 | Craig Hallum | Buy |
| 2018-11-20 | 개시 | H.C. Wainwright | Buy |
모두보기
Celcuity Inc 주식(CELC)의 최신 뉴스
Is Celcuity (NASDAQ:CELC) Using Debt Sensibly? - simplywall.st
Celcuity Inc. (NASDAQ:CELC) Stock Holdings Lifted by Vanguard Group Inc. - Defense World
Where are the Opportunities in (CELC) - news.stocktradersdaily.com
Celcuity Inc. (NASDAQ:CELC) Shares Purchased by Wellington Management Group LLP - Defense World
Corebridge Financial Inc. Has $213,000 Position in Celcuity Inc. (NASDAQ:CELC) - Defense World
Needham & Company LLC Reiterates “Buy” Rating for Celcuity (NASDAQ:CELC) - Defense World
Celcuity at Needham Conference: New Frontiers in Cancer Treatment By Investing.com - Investing.com Canada
Celcuity at Stifel Forum: Insights on Cancer Drug Trials By Investing.com - Investing.com Canada
Greenbrier, RPM International, CVRx And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
Celcuity projects $2B revenue potential for gedatolisib in second-line breast cancer market - MSN
What is HC Wainwright’s Forecast for Celcuity Q1 Earnings? - The AM Reporter
Celcuity Stock Hits 52-Week Low at $8.46 Amid Market Challenges - Investing.com Australia
Celcuity Stock Hits 52-Week Low at $8.46 Amid Market Challenges By Investing.com - Investing.com South Africa
Research Analysts Offer Predictions for Celcuity Q1 Earnings - Defense World
Celcuity Announces Closing of Common Stock Offering and Full Exercise of Underwriter's Option to Purchase Additional Shares of Common Stock - ACCESS Newswire
Celcuity (NASDAQ:CELC) Receives Buy Rating from Needham & Company LLC - Defense World
Celcuity (NASDAQ:CELC) Given Buy Rating at HC Wainwright - Defense World
Brokerages Set Celcuity Inc. (NASDAQ:CELC) PT at $30.17 - Defense World
Celcuity Inc. Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update - ACCESS Newswire
Celcuity Stock (CELC) Dips Despite Promising Cancer Treatment in Pipeline - The Globe and Mail
Celcuity Inc. Earnings Call Highlights Progress and Challenges - TipRanks
Stifel maintains Celcuity stock Buy rating, $42 target By Investing.com - Investing.com Canada
Celcuity Inc (NASDAQ:CELC) Misses Earning Expectations - FXDailyReport.Com
Stifel maintains Celcuity stock Buy rating, $42 target - Investing.com
Celcuity Inc. (NASDAQ:CELC) Q4 2024 Earnings Call Transcript - Insider Monkey
Celcuity To Present at Upcoming Needham and Stifel Investor Conferences - GlobeNewswire
Celcuity Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update - The Manila Times
Celcuity Inc. Reports 2024 Financial Results and Clinical Updates - TipRanks
Earnings call transcript: Celcuity Q4 2024 reveals wider losses By Investing.com - Investing.com Canada
Celcuity Inc. SEC 10-K Report - TradingView
Celcuity Inc reports results for the quarter ended December 31Earnings Summary - TradingView
CELCUITY Earnings Results: $CELC Reports Quarterly Earnings - Nasdaq
Earnings Scheduled For March 31, 2025 - Benzinga
Celcuity Inc (CELC) Q4 2024 Earnings Call Highlights: Navigating Financial Challenges with ... By GuruFocus - Investing.com Canada
(CELC) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Charles Schwab Investment Management Inc. Has $3.11 Million Stock Position in Celcuity Inc. (NASDAQ:CELC) - Defense World
Bank of New York Mellon Corp Buys 10,828 Shares of Celcuity Inc. (NASDAQ:CELC) - Defense World
Celcuity Inc. Schedules Release of Fourth Quarter and Full Year 2024 Financial Results and Webcast/Conference Call - GlobeNewswire
Celcuity (CELC) Projected to Post Quarterly Earnings on Wednesday - Defense World
Celcuity at Leerink Global Healthcare Conference: Promising Cancer Drug Insights By Investing.com - Investing.com South Africa
Celcuity at Leerink Global Healthcare Conference: Promising Cancer Drug Insights - Investing.com Canada
BlackRock, Inc. Expands Holdings with Celcuity Inc. Acquisition - GuruFocus
Rhumbline Advisers Boosts Position in Celcuity Inc. (NASDAQ:CELC) - Defense World
(CELC) Technical Data - Stock Traders Daily
Brokerages Set Celcuity Inc. (NASDAQ:CELC) Target Price at $30.17 - Defense World
Celcuity, Inc. to Host Earnings Call - ACCESS Newswire
New York State Common Retirement Fund Purchases 3,682 Shares of Celcuity Inc. (NASDAQ:CELC) - Defense World
Oncology Breakthroughs: How Cancer Research Is Advancing in 2025 - The Malaysian Reserve
(CELC) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Celcuity stock touches 52-week low at $10.35 amid market challenges - Investing.com India
Celcuity stock touches 52-week low at $10.35 amid market challenges By Investing.com - Investing.com South Africa
Celcuity Inc (CELC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.15%
4.32%
자본화:
|
볼륨(24시간):